About this trial
The purpose of this study was to investigate the effect of bupivacaine liposomes on postoperative pain in TKA ( total knee replacement ) patients.The main questions answered are:
1. Is bupivacaine liposomes superior to bupivacaine in femoral triangle block or adductor block in terms of 72 hours opioid consumption after knee replacement 2. Which block method(Femoral triangle block or adductor block) combined with bupivacaine liposome was more effective in alleviating pain score and 72 hours opioid consumption after total knee surgery.
investigators will investigate the effect of bupivacaine liposomes combined with bupivacaine and pure bupivacaine on pain after total knee arthroplasty using femoral triangle block or adductor block.
Participants will:
1. Receive liposomal bupivacaine or bupivacaine as a regional anesthetic for femoral triangle block or adductor block under ultrasound guidance. 2. Undergo total knee replacement surgery under spinal anesthesia. 3. Follow-up within 72 hours after surgery , opioid consumption, NRS score, PCA(Patient controlled analgesia,PCA) data, first postoperative remedial analgesia time, quadriceps muscle strength and complications were recorded
Eligibility criteria
Qualifiers
Patients with ASAI-ⅲ
Receive a unilateral initial TKA
Age 18-80 years old -
Disqualifiers
Bilateral TKA surgery
TKA revision surgery
Contraindications for nerve block and intraspinal anesthesia
Allergies to local anesthetics
Trial design
Treatments tested in this trial
- Bupivacaine liposome
- Nerve block mode : adductor block
- Bupivacaine
- Nerve block mode: femoral triangle block